Results 61 to 70 of about 10,947 (175)

Depression in Parkinson's disease [PDF]

open access: yes, 2014
The prevalence of major and minor depression in Parkinson’s disease is around 30–40% but, unfortunately, depression remains frequently underrecognized and often undertreated.
Döme, Péter   +2 more
core  

MODERN INDICATIONS FOR THE USE OF OPIPRAMOL [PDF]

open access: yes, 2015
Opipramol is considered as a pharmacological agent that does not fit the classification taking into account the division of antidepressants, antipsychotics and anxiolytics.
J. Cubała, Wiesław   +8 more
core   +1 more source

Acute and repeated treatment with the 5-HT_7 receptor antagonist SB 269970 induces functional desensitization of 5-HT_7 receptors in rat hippocampus [PDF]

open access: yes, 2012
Bobula, Bartosz   +8 more
core   +1 more source

TREATMENT OF DEPRESSION IN PATIENTS WITH OSTEOARTHRITIS: THE IMPORTANCE OF AN EARLY DIAGNOSIS AND THE ROLE OF DULOXETINE [PDF]

open access: yes, 2016
Background: Osteoarthritis (OA) also called degenerative joint disease is the most common chronic condition of the joints that just in 2004, caused moderate to severe disability in 43.4 million of people.
Agius, Mark, Jesus, Cátia, Jesus, Inês
core   +1 more source

Antidepressants in epilepsy [PDF]

open access: yes, 2019
People with epilepsy (PWE) frequently suffer from comorbid mood and anxiety disorders. Depression is one of the major psychiatric comorbidities having a negative impact on the quality of life in people with epilepsy.
Cubała, Wiesław Jerzy   +4 more
core   +1 more source

Antidepressants for people with epilepsy and depression [PDF]

open access: yes, 2014
Adams   +32 more
core   +1 more source

Antidepressants versus placebo for depression in primary care [PDF]

open access: yes, 2009
Arroll, Bruce   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy